<p><strong>Oramed Pharmaceuticals Inc.</strong>（纳斯达克代码：ORMP - 获取免费报告）于 1 月 7 日（星期三）宣布派发股息。1 月 16 日（星期五）登记在册的股东将于 1 月 26 日（星期一）获得生物技术公司每股 0.25 的股息。除息日期为 1 月 16 日（星期五）。</p>
<p>获取 <strong>Oramed Pharmaceuticals</strong> 的提醒：</p>
<h2>Oramed Pharmaceuticals 股票表现</h2>
<p>在周四的交易时段，纳斯达克：ORMP 上涨了 0.21 美元，达到了 3.48 美元。该股票的交易量为 311,721 股，而其平均交易量为 193,109 股。该公司的 50 日移动平均线为 2.72 美元，200 日移动平均线为 2.41 美元。公司的市值为 1.3831 亿美元，市盈率为 2.76，贝塔值为 1.19。Oramed Pharmaceuticals 的年内最低价为 1.82 美元，年内最高价为 3.50 美元。</p>
<h2>关于 Oramed Pharmaceuticals</h2>
<p>（获取免费报告）</p>
<p>Oramed Pharmaceuticals Inc 是一家临床阶段的生物技术公司，专注于开发专有的口服药物递送系统，最初重点关注糖尿病管理。公司总部位于以色列耶路撒冷，利用其专利的蛋白质包封技术——“口服递送平台”，将注射疗法转变为患者友好的口服制剂。Oramed 的平台旨在保护敏感的蛋白质和肽免受胃肠道降解，从而实现成功的吸收和系统性递送。</p>
<p>公司的主要候选药物 ORMD-0801 是一种用于 2 型糖尿病患者的口服胰岛素胶囊，目前正在进行第三阶段临床试验。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票比 Oramed Pharmaceuticals 更好</li>
<li>崩盘前一个月</li>
<li>家族信托如何帮助保护你的财富</li>
<li>市场恐慌：特朗普刚刚对你的股票投下了一颗炸弹</li>
<li>YDES 可能是 2026 年的生物技术突破</li>
<li>每天一次，持续一小时</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Oramed Pharmaceuticals 吗？</h2>
<p>在考虑 Oramed Pharmaceuticals 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oramed Pharmaceuticals 并不在名单上。</p>
<p>虽然 Oramed Pharmaceuticals 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Oramed Pharmaceuticals Inc.（纳斯达克代码：ORMP）宣布每股派息 0.25 美元，支付日期为 1 月 26 日，股东登记截止日期为 1 月 16 日。除息日期也是 1 月 16 日。该公司的股票最近交易价格为 3.48 美元，市值为 1.3831 亿美元，市盈率为 2.76。Oramed 专注于开发口服药物递送系统，特别是用于糖尿病管理，其主要候选药物 ORMD-0801 目前正在进行第三阶段临床试验</p>

<p><strong>Oramed Pharmaceuticals Inc.</strong> (NASDAQ:ORMP - Get Free Report) declared a dividend on Wednesday, January 7th. Stockholders of record on Friday, January 16th will be given a dividend of 0.25 per share by the biotechnology company on Monday, January 26th. The ex-dividend date is Friday, January 16th.</p>
<div class="lb-trans"><p><strong>Oramed Pharmaceuticals Inc.</strong>（纳斯达克代码：ORMP - 获取免费报告）于 1 月 7 日（星期三）宣布派发股息。1 月 16 日（星期五）登记在册的股东将于 1 月 26 日（星期一）获得生物技术公司每股 0.25 的股息。除息日期为 1 月 16 日（星期五）。</p>
</div><p>Get <strong>Oramed Pharmaceuticals</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Oramed Pharmaceuticals</strong> 的提醒：</p>
</div><h2>Oramed Pharmaceuticals Stock Performance</h2>
<div class="lb-trans"><h2>Oramed Pharmaceuticals 股票表现</h2>
</div><p>NASDAQ:ORMP traded up $0.21 during trading hours on Thursday, hitting $3.48. The stock had a trading volume of 311,721 shares, compared to its average volume of 193,109. The business's 50 day moving average is $2.72 and its 200-day moving average is $2.41. The company has a market cap of $138.31 million, a price-to-earnings ratio of 2.76 and a beta of 1.19. Oramed Pharmaceuticals has a one year low of $1.82 and a one year high of $3.50.</p>
<div class="lb-trans"><p>在周四的交易时段，纳斯达克：ORMP 上涨了 0.21 美元，达到了 3.48 美元。该股票的交易量为 311,721 股，而其平均交易量为 193,109 股。该公司的 50 日移动平均线为 2.72 美元，200 日移动平均线为 2.41 美元。公司的市值为 1.3831 亿美元，市盈率为 2.76，贝塔值为 1.19。Oramed Pharmaceuticals 的年内最低价为 1.82 美元，年内最高价为 3.50 美元。</p>
</div><h2>About Oramed Pharmaceuticals</h2>
<div class="lb-trans"><h2>关于 Oramed Pharmaceuticals</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Oramed Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of proprietary oral drug delivery systems, with an initial emphasis on diabetes management. Headquartered in Jerusalem, Israel, the company leverages its patented protein encapsulation technology, the “Oral Delivery Platform,” to transform injectable therapies into patient-friendly oral formulations. Oramed's platform is designed to protect sensitive proteins and peptides from degradation in the gastrointestinal tract, enabling successful absorption and systemic delivery.</p>
<div class="lb-trans"><p>Oramed Pharmaceuticals Inc 是一家临床阶段的生物技术公司，专注于开发专有的口服药物递送系统，最初重点关注糖尿病管理。公司总部位于以色列耶路撒冷，利用其专利的蛋白质包封技术——“口服递送平台”，将注射疗法转变为患者友好的口服制剂。Oramed 的平台旨在保护敏感的蛋白质和肽免受胃肠道降解，从而实现成功的吸收和系统性递送。</p>
</div><p>The company's lead candidate, ORMD-0801, is an oral insulin capsule for patients with type 2 diabetes, currently advancing through Phase 3 clinical trials.</p>
<div class="lb-trans"><p>公司的主要候选药物 ORMD-0801 是一种用于 2 型糖尿病患者的口服胰岛素胶囊，目前正在进行第三阶段临床试验。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Oramed Pharmaceuticals</li>
<li>A month before the crash</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Market Panic: Trump Just Dropped a Bomb on Your Stocks</li>
<li>YDES Could Be 2026's Biotech Breakthrough</li>
<li>1 Hour Once A Day</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Oramed Pharmaceuticals 更好</li>
<li>崩盘前一个月</li>
<li>家族信托如何帮助保护你的财富</li>
<li>市场恐慌：特朗普刚刚对你的股票投下了一颗炸弹</li>
<li>YDES 可能是 2026 年的生物技术突破</li>
<li>每天一次，持续一小时</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oramed Pharmaceuticals Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Oramed Pharmaceuticals 吗？</h2>
</div><p>Before you consider Oramed Pharmaceuticals, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oramed Pharmaceuticals 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oramed Pharmaceuticals wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oramed Pharmaceuticals 并不在名单上。</p>
</div><p>While Oramed Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oramed Pharmaceuticals 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oramed Pharmaceuticals Inc. 宣布将派发每股 0.25 美元的股息（NASDAQ: ORMP）